Stockreport

Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights

Biomea Fusion, Inc.  (BMEA) 
PDF Reported positive data from the escalation portion of Phase 1/2 study (COVALENT-111) in type 2 diabetes patients, displaying durable improved glycemic control while off [Read more]